Clinical Trial

Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali

Study acronym: SANTE
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The double blind randomized controlled trial will assess the efficacy of oral azithromycin administered to pregnant women and/or infants during routine care in preventing stillbirths and mortality through 6-12 months of age in Mali, West Africa, where rates of infant and under five mortality are among the highest in the world.
Protocol Amendment History 1 change
minor Completion pushed: 2026-03-31 -> 2027-03-31 2026-08-08
Trial Details
NCT Number NCT03909737
Lead Sponsor University of Maryland, Baltimore
Collaborators: Bill and Melinda Gates Foundation
Conditions Stillbirths and Infant Mortality
Enrollment 99,700 participants
Start Date 2020-09-24
Primary Completion 2025-03-01 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-07